<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01340287</url>
  </required_header>
  <id_info>
    <org_study_id>NU281</org_study_id>
    <nct_id>NCT01340287</nct_id>
  </id_info>
  <brief_title>Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols</brief_title>
  <official_title>Effects of the Consumption of a Plant Sterols-enriched Dairy Fermented Product on Hypercholesterolemia Management in Hypercholesterolemic Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danone Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danone Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the cholesterol lowering effect of a drinkable
      low fat fermented milk enriched with plant sterol after 3 and 6 weeks of daily consumption in
      midly hypercholesterolemic people not treated by statins.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">168</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>1 = Tested product</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2 = Control product</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>1- plain low-fat dairy fermented product (drinkable) enriched with plant sterols-esters (1,6g /day equivalent as free sterols).</intervention_name>
    <description>1 = Intervention 1 (1 test product/day)</description>
    <arm_group_label>1 = Tested product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>2- plain low-fat dairy fermented product (drinkable) without plant sterols-esters</intervention_name>
    <description>2 = Intervention 2 (1 control product/day)</description>
    <arm_group_label>2 = Control product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male/female subject,

          -  aged from 21 to 75 years,

          -  BMI between 19 and 30 kg/m2,

          -  LDL-cholesterol plasma level between 130 and 190 mg/dL without statin monotherapy,

          -  stabilized hypercholesterolemia,

          -  accepting to follow the dietary recommendations advisable for hypercholesterolemic
             patient (NCEP-ATP III guidelines),

          -  used to consume dairy products,

          -  effective contraceptive methods used for female subjects,

          -  having given written consent to take part in the study

        Exclusion Criteria:

          -  subject with plasma triglycerides (TG) levels â‰¥ 350 mg/dL,

          -  having experienced any cardiovascular event in the last 6 months,

          -  taking any hypocholesterolemic treatment,

          -  diabetic subject (type I and type II),

          -  smoking strictly more than 10 cigarettes / day,

          -  heavy alcohol intake (&gt; 40 g / day for men ; &gt; 30 g / day for women),

          -  presenting known allergy or hypersensitivity to milk proteins,

          -  known soy allergy,

          -  refusing to stop the consumption of plant sterols-enriched products (other than the
             studied product),

          -  receiving systemic treatment or topical treatment likely to interfere with evaluation
             of the study parameters,

          -  receiving a transplant and under immunosuppressor treatment,

          -  currently involved in a clinical trial or in an exclusion period following
             participation in another clinical trial,

          -  in a situation which in the investigator's opinion could interfere with optimal
             participation in the present study or could constitute a special risk for the subject,

          -  with any kind of disease likely to interfere with the evaluation of efficiency or
             safety of the product,

          -  for female subject: pregnancy, breast feeding or intention to be pregnant during the
             study or subject likely to change her contraceptive method during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Renstar Medical Research</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2011</study_first_submitted>
  <study_first_submitted_qc>April 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2011</study_first_posted>
  <last_update_submitted>October 26, 2016</last_update_submitted>
  <last_update_submitted_qc>October 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Plant sterol</keyword>
  <keyword>Hypercholesterolemia</keyword>
  <keyword>diet</keyword>
  <keyword>dairy</keyword>
  <keyword>isoprostanes</keyword>
  <keyword>Midly hypercholesterolemic subjects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

